|
Post by sportsrancho on Sept 24, 2016 7:24:24 GMT -5
Kc- for the most part I think you are a more level headed share holder then most but who is going to pay 5-7.5 billion for a company that makes less then 1 million a month. A company that realizes Afrezza is a game changer and has the firepower to drive it - and drive down their competitions market cap. Seems like a big game of chicken. Also they know already that it's a game changer. At least SNY does. But will it sell, and be embraced by PWD's and the medical community? We need to raise enough money to give us time to prove that. And by that time we could have something else in the pipe line. Be close to breaking even and won't want to sell. So PB has a small window to make the move if they want us at all IMO.
|
|
|
Post by sportsrancho on Sept 24, 2016 12:58:06 GMT -5
|
|
|
Post by mnkdfann on Sept 25, 2016 0:19:30 GMT -5
A few weeks ago, Castagna posted on twitter that "Moving forward Rxs will only come from MNKD directly via the website."
Has anyone seen them posted on the website? If so, where / what page?
|
|
|
Post by babaoriley on Sept 25, 2016 1:13:16 GMT -5
Fellow Longs, today marks the day we should all face the facts...MannKind is done. Since August 2015 I believed (& bought; ultimately I've lost -$35k+) Afrezza/Technosphere could improve patients lives and change modern medicine. Unfortunately no amount of good news (the script uptrend, that supposed MLB advertising bullsh*t which will not happen, the stellar ADA+JDRF reviews, etc) can save this company. It is too little to late especially with the staggering & unrelenting short position. Liane can edit & delete posts hiding the scary truth: management squandered a golden opportunity, failed patients and screwed shareholders forever. Only a miracle like Novo Nordisk could save MannKind now and we all know that is not happening. This is a tragic damn shame how this story ended: PWD around the world will never discover the benefits of Afrezza. Big bio-pharma buried disruptive innovation and shorts have won. Tron, you've definitely made many longs very jealous - "ultimately I've lost -$35k+" - for a guy who sounds as sharp and as experienced as you, I wouldn't think $35K in the market would hurt that much, sorry if it does. Management's golden opportunity was not squandered, rather it was firmly seized - approval followed by a deal with one of the biggest pharmas in the world, well-known for peddling insulin. Blew up in all longs' faces; isn't the first time, won't be the last time. Hardly any long here had a problem with SNY when the deal was announced (quite the opposite); sure, there was grousing over the deal, the up-front money, the split, etc., but not about making a deal with a big pharma, and specifically, SNY. Additionally, some amount of good news can save the company. Shorts have won for years, perhaps the tables will turn. No one wins all the time and no one loses all the time. But for many, the losses are remembered longer and more vividly than the wins. Human nature.
|
|
|
Post by winstonsmith on Sept 25, 2016 6:04:13 GMT -5
Isn't there a huge $1.5 Billion deferred tax benefit that would go along with the purchase?
|
|
|
Post by LosingMyBullishness on Sept 25, 2016 6:21:15 GMT -5
trondisc-sadly, I think you are correct. Nothing short of a Hail Mary can save this company now, and I don't see that on the horizon. I rue the day I first heard of MNKD. If I had been cutting the grass instead of trolling the YMB message boards on the day I came across MNKD, I'd be $30,000 richer right now. Oh well, such is life-time to move on. Rvc, all the best for you and your future investments. I wonder why so many on this board announce to sell their shares. Do you want us to join in to convince yourself to actually sell them? As a shorts tactic is would be rather blunt.
|
|
|
Post by LosingMyBullishness on Sept 25, 2016 6:35:33 GMT -5
How would that affect the shares that the employees and foundations own? I can't see ch11 happening unless the employees and foundations shares are exempt... And if that is the case they are going to face a heck of a lawsuit from the share holders that were left out in the cold. Nobody is exempt other Than secured notes and preferred stock. Everybody gets wiped out. Better to sell the company get $10 to $15 and a chance for #afrezza to develop into a blockbuster. Hopefully board is actively marketing the company. kc, you have been preaching this since Jan, if I recall correctly. It doesn't work. We wouldn't get that price. Right now we probably would just get the market value. The option you wish for simply does not exist. Management is doing exactly what is possible right now: Improving scripts to show that there is a market, doing limited marketing and developing an epi-alternative. Why is this so difficult to accept? First the word "game" is a four letter obscenity to the working class which invests their life money. Second, the stock market is an investment plan. Protected by the government (we the people by the people and for the people) through the Security and Exchange Commission. Mary Jo White was quoted in the last few weeks, "I know there is a problem in trading that gives advantage toward non-stock supporters and that trade methods can be used to give them advantage. The problem with the Current trade methods is the rules and the lack of support data collected to backup discovery of Creativity Manipulation. The markets need to be monitored, statistics gathered so numbers may be created.The who, what, where, how and why is very important and needs to be known not only for MNKD, but for all stock funded corporations and their investors. The use of naked shares needs to be placed at their truly represented value ZERO with no trade power. If you wish to obtain naked shares that is your business, but a waiting period is needed because it should take owner held shares to relinquish. Naked Shares, relinquishment to BID shares, widen spread window for new lower ASK order relinquishment, four decimal trading and market volatility go hand in hand. Creativity Manipulation through trade motion caused the Flash Crash. Creativity Manipulation destroyed NVAX in the after hours. Creativity Manipulation controls the flow of the top Current Bid and Ask page and done electronically or manually would be illegal if data were collected. Alfred Mann had an Eureka moment when he discovered Afrezza, I enjoy watching him on a u-tube describe that moment. I believe in his talent and ability as a good example as well as those that stood and still stand for MANNKIND. It may look bleak, but ten days at a dollar reinstates the stock. That value is nothing to obtain if the market adjusts. Nobody wins with a stock reversal and that will be a last resort. Market usage by diabetics and their testimonials to family, friends and doctors is the key, insurance coverage a plus and SEC support a blessing.
|
|
|
Post by mnkdfann on Sept 25, 2016 9:44:39 GMT -5
Isn't there a huge $1.5 Billion deferred tax benefit that would go along with the purchase? Yes, there is a big deferred tax number. But some people in these threads (james, chuck, etc.) argue that it has limited value in a buyout. mnkd.proboards.com/thread/4827/mnkds-operating-carry-forward-balance"The reported NOL is $2.6B, but you will need a tax lawyer to figure out what that is worth. It's worth a whole lot if MNKD becomes profitable in it's current form, not so much if it changes ownership. There are considerable limitations on how much of that could be applied by an acquiring party according to section 382 of the code. I'm not qualified to describe that or give any reliable estimate. But if you want a weakly informed opinion, I would say it's worth less than $100M." mnkd.proboards.com/thread/5029/reuters-mannkind-nasdaq-mnkd-exploring"Loss carryforward has little if any value in a buyout situation. This is well known to anyone doing M&A due to restrictions in use of NOL's after change in control."
|
|
|
Post by kc on Sept 25, 2016 10:46:16 GMT -5
Nobody is exempt other Than secured notes and preferred stock. Everybody gets wiped out. Better to sell the company get $10 to $15 and a chance for #afrezza to develop into a blockbuster. Hopefully board is actively marketing the company. kc, you have been preaching this since Jan, if I recall correctly. It doesn't work. We wouldn't get that price. Right now we probably would just get the market value. The option you wish for simply does not exist. Management is doing exactly what is possible right now: Improving scripts to show that there is a market, doing limited marketing and developing an epi-alternative. Why is this so difficult to accept? First the word "game" is a four letter obscenity to the working class which invests their life money. Second, the stock market is an investment plan. Protected by the government (we the people by the people and for the people) through the Security and Exchange Commission. Mary Jo White was quoted in the last few weeks, "I know there is a problem in trading that gives advantage toward non-stock supporters and that trade methods can be used to give them advantage. The problem with the Current trade methods is the rules and the lack of support data collected to backup discovery of Creativity Manipulation. The markets need to be monitored, statistics gathered so numbers may be created.The who, what, where, how and why is very important and needs to be known not only for MNKD, but for all stock funded corporations and their investors. The use of naked shares needs to be placed at their truly represented value ZERO with no trade power. If you wish to obtain naked shares that is your business, but a waiting period is needed because it should take owner held shares to relinquish. Naked Shares, relinquishment to BID shares, widen spread window for new lower ASK order relinquishment, four decimal trading and market volatility go hand in hand. Creativity Manipulation through trade motion caused the Flash Crash. Creativity Manipulation destroyed NVAX in the after hours. Creativity Manipulation controls the flow of the top Current Bid and Ask page and done electronically or manually would be illegal if data were collected. Alfred Mann had an Eureka moment when he discovered Afrezza, I enjoy watching him on a u-tube describe that moment. I believe in his talent and ability as a good example as well as those that stood and still stand for MANNKIND. It may look bleak, but ten days at a dollar reinstates the stock. That value is nothing to obtain if the market adjusts. Nobody wins with a stock reversal and that will be a last resort. Market usage by diabetics and their testimonials to family, friends and doctors is the key, insurance coverage a plus and SEC support a blessing. I don't disagree that we need Scripts to be rising. But we also need to have cash. More dilution does not help any of us who are long. On the other hand filing Chapter 11 would eliminate all the common shareholders. Only the Board of Directors and management know what they are planning to do. If I was sitting on the Board of Directors and could not raise the needed additional cash without dilution, I would look at the long-term option, and in my mind that would be sale of the company. With such a low stock price we do not really know who has been accumulating shares. Perhaps it's somebody waiting to announce a 10% stake in the company or perhaps it's all the institutional investors selling out. They seem to know better than we do as individual investors on how to get out of a stock that is having a difficult time. I have always been a supporter of the board and management so I hope they do the right thing for the common shareholder.
|
|
|
Post by tayl5 on Sept 25, 2016 11:11:32 GMT -5
Fellow Longs, today marks the day we should all face the facts...MannKind is done. Since August 2015 I believed (& bought; ultimately I've lost -$35k+) Afrezza/Technosphere could improve patients lives and change modern medicine. Unfortunately no amount of good news (the script uptrend, that supposed MLB advertising bullsh*t which will not happen, the stellar ADA+JDRF reviews, etc) can save this company. It is too little to late especially with the staggering & unrelenting short position. Liane can edit & delete posts hiding the scary truth: management squandered a golden opportunity, failed patients and screwed shareholders forever. Only a miracle like Novo Nordisk could save MannKind now and we all know that is not happening. This is a tragic damn shame how this story ended: PWD around the world will never discover the benefits of Afrezza. Big bio-pharma buried disruptive innovation and shorts have won. It ain't over. We're plucky.
|
|
|
Post by sweedee79 on Sept 25, 2016 11:32:36 GMT -5
Fellow Longs, today marks the day we should all face the facts...MannKind is done. Since August 2015 I believed (& bought; ultimately I've lost -$35k+) Afrezza/Technosphere could improve patients lives and change modern medicine. Unfortunately no amount of good news (the script uptrend, that supposed MLB advertising bullsh*t which will not happen, the stellar ADA+JDRF reviews, etc) can save this company. It is too little to late especially with the staggering & unrelenting short position. Liane can edit & delete posts hiding the scary truth: management squandered a golden opportunity, failed patients and screwed shareholders forever. Only a miracle like Novo Nordisk could save MannKind now and we all know that is not happening. This is a tragic damn shame how this story ended: PWD around the world will never discover the benefits of Afrezza. Big bio-pharma buried disruptive innovation and shorts have won. Ive read many of your posts and I always feel angst... in fact Id like to bring out my boxing gloves.... if you don't like it... get a movin...
|
|
|
Post by rockstarrick on Sept 25, 2016 12:09:36 GMT -5
kc, you have been preaching this since Jan, if I recall correctly. It doesn't work. We wouldn't get that price. Right now we probably would just get the market value. The option you wish for simply does not exist. Management is doing exactly what is possible right now: Improving scripts to show that there is a market, doing limited marketing and developing an epi-alternative. Why is this so difficult to accept? I don't disagree that we need Scripts to be rising. But we also need to have cash. More dilution does not help any of us who are long. On the other hand filing Chapter 11 would eliminate all the common shareholders. Only the Board of Directors and management know what they are planning to do. If I was sitting on the Board of Directors and could not raise the needed additional cash without dilution, I would look at the long-term option, and in my mind that would be sale of the company. With such a low stock price we do not really know who has been accumulating shares. Perhaps it's somebody waiting to announce a 10% stake in the company or perhaps it's all the institutional investors selling out. They seem to know better than we do as individual investors on how to get out of a stock that is having a difficult time. I have always been a supporter of the board and management so I hope they do the right thing for the common shareholder. I believe if Mnkd were sold now, the most we could hope for would be 1.5 * the current shareprice, so $1/share max IMO. Im hoping they wait until the shareprice is a little more representative of the type of drug Afrezza could be, (Blockbuster) keep those rx #'s rising Mike, it's coming, I have great respect and confidence in the team and strategy Mike is deploying, just need a little more time. Can't believe I bought for .65 Friday 🎯
|
|
|
Post by madog365 on Sept 26, 2016 12:42:22 GMT -5
Tron: I'm concerned about your mental health. So much rage, expressed over and over on a message board. Some here have bid you a respectful goodbye, but you refuse to go. Sad. So you aren't disappointed nor upset in the slightest that the PPS isn't even stabilizing but ACCELERATING downward? Meanwhile Pfeffer sits idly on his hands watching Al Mann's 10+ years of R&D billions evaporated into oblivion? You are not long so stop pretending. Your only goal here is to push your negative agenda in hopes that eventually Mannkind will be buried financially. Very sad that you and a few others on this board have devoted your time and money to making sure diabetics never even have a chance to try this live savings medication. Really speaks to how much of an opportunistic cretin you are.
|
|
|
Post by afrizzle on Sept 26, 2016 14:34:09 GMT -5
As my stockbroker buddy always says. If you're going to jump out of the window over it, make sure you're on the first floor
|
|
|
Post by kc on Sept 26, 2016 15:34:57 GMT -5
As my stockbroker buddy always says. If you're going to jump out of the window over it, make sure you're on the first floor I think that I actually posted an image of that one time on Stocktwits. I hate my loss and it will be very painful if the company goes chapter 11. But the product is a great one and will eventually become the gold standard for diabetes treatment.
One has to balance a capital loss with a capital gain. while that is not always the situation for most if you have that opportunity to di that you should. Take your loss and get out for the 30 days required for a loss sale. You don't have to sell off of your shares just what you need for tax purposes. Otherwise you can only write off $3,000.00 of loss each year. So if you have a huge capital gain on another stock or a sale of a piece of real estate take it now. Then come back in in 30 or 40 day. The share price will still be sub 1.00 unless something happens in that time frame. I take advice and I also take my own advice.
MannKind long term outlook while it looks bleak today,
I for one still believe that the board of Directors will sell the company before having to deal with a chapter 11 filing.
Nobody but the secured creditors win in a chapter 11. I stated Last January, February and again in March that MannKind needs to be sold and put into the hands of a Pharma who wants a blockbuster potential drug.
Is there one out there?
I believe there is but my guess is that Management and the Board wants to prove the value of Afrezza before selling the company for a sub $10.00 price.
Am I naïve? I don't thing so.
I Really believe that if we have enough time to get some sales the company will be sold for a fair price in the $15 to $20 range. A buyer is not buying todays share price but the potential that the product brings in future sales both domestically and internationally .
|
|